FindTrial
Sign In

Multi-center, cohort study for the treatment and impact factors on patients with MDR/RR-TB in China

Multi-center, cohort study for the treatment and impact factors on patients with MDR/RR-TB in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075690
Enrollment
Unknown
Registered
2023-09-13
Start date
2023-09-15
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

drug-resistant tuberculosis

Interventions

Case series:NA

Sponsors

shanghai pulmonary hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 80 Years

Inclusion criteria

Inclusion criteria: patients included meet criteria following below: ? hospitalized, confirmed as MDR/RR-TB, including children, adolescent, adult and elders; ? Pulmonary tuberculosis patients with sputum culture positive, and DST indicating at least resistant to INH and RFP, or confirmed by Xpert MTB/RIF resistant to RFP; ? informed consent by participants; ? fully protected the privacy of participants.

Exclusion criteria

Exclusion criteria: patients with the following the situations were excluded from the study: ? confirmed by culture idenfication as NTM infection. ?not suitable for chemotherapy for patients with MDR/RR-TB after clinical judgment

Design outcomes

Primary

MeasureTime frame
treatment success rate;—

Secondary

MeasureTime frame
AE rate;Phlegm culture negative conversion rate;Lesion absorption rate;Void closure rate;—

Countries

China

Contacts

Public ContactFan Lin

Shanghai pulmonary hospital

1609556230@qq.com+86 139 1856 9516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026